Observational studyClinical rheumatology2019

Outcomes of dose reduction, withdrawal, and restart of tofacitinib in patients with rheumatoid arthritis: a prospective observational study.

Shunsuke Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.